Low-Dose Zoladex Withdrawn: Patient Impact Explained
AstraZeneca is pulling low-dose Zoladex from the Australian market from November 2026. This affects prostate cancer, breast cancer, and endometriosis patients. Learn about alternatives and what to do.
